|
|
|
|
COVID-19 INFECTION AND AUTOIMMUNE REACTIONS
N.I. Lisyany
Institute of Neurosurgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz68.01.087
Abstract
The review considers various mechanisms for the development
of autoimmune complications after COVID-19 disease. The
significance of hyperactivation of the immune system with
impaired tolerance is analyzed in detail, the issues of molecular
mimicry and antigenic similarity of virus and human epitopes
are considered. High expression of some autoimmune antigens
and high levels of autoantibodies to a wide range of human
antigens have been shown. The cytotoxicity and blocking effect
of specific antiviral antibodies on various cells and tissues of
the body and the importance of viral antigens as co-stimulatory
molecules for the activation of T- and B-lymphocytes are
discussed separately. The review hypothesizes “postcovidal
humoral autoimmunity” based on an autoimmune response to
various antigens and auto antigens that may cause autoimmune
diseases of COVID-19 infection.
Keywords:
COVID-19 infection; autoimmune diseases; cytokine storm; molecular mimicry; auto antibodies; autoantigens.
References
- Shoenfeld Y, Gilburd B, Abu-Shakra M. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10(1):3.
- Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J. 2008;10(1):8.
- Shoenfeld Y, Blank M, Abu-Shakra M. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J. 2008;10(1):13.
- Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021 Apr;20(4):102792.
CrossRef
PubMed PubMedCentral
- Ehrenfeld M, Tincani A, Andreoli L. Covid-19 and autoimmunity. Autoimmun. Rev. 2020 Dec;19(12):102695.
CrossRef
PubMed PubMedCentral
- Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARSCoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020 Jul;108(1):17-41.
CrossRef
PubMed PubMedCentral
- Ragab D, Salah E, Taeimah H, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446.
CrossRef
PubMed PubMedCentral
- Tay M, Poh C, Rénia L, MacAry P, Ng L. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020:1-2.
CrossRef
PubMed PubMedCentral
- Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensiv Care Med. 2020;46(5):846-8.
CrossRef
PubMed PubMedCentral
- Hasan S, Capstick T, Ahmed R, Kow C, Mazhar F, Merchant H. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Exp Rev Respir Med. 2020;14(11):1149-63.
CrossRef
PubMed PubMedCentral
- Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 immunobiology: Lessons learned, new questions arise. Front Immunol. 2021 Aug 26;12:719023.
CrossRef
PubMed PubMedCentral
- Icenogle T. COVID-19: Infection or autoimmunity. Front Immunol. 2020;11:2055.
CrossRef
PubMed PubMedCentral
- Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762.
CrossRef
PubMed PubMedCentral
- Tang KT, Hsu BC, Chen DY. Autoimmune and rheumatic manifestations associated with COVID-19 in adults: An updated systematic review. Front Immunol. 2021; 12:645013.
CrossRef
PubMed PubMedCentral
- Knochelmann HM, Dwyer CJ, Bailey SR, Amaya SM, Elston DM, Mazza-McCrann JM, et al. When worlds collide: Th17 and treg cells in cancer and autoimmunity. Cell Mol Immunol. 2018;15(5):458-69.
CrossRef
PubMed PubMedCentral
- Liblau RS, Wong FS, Mars LT, Santamaria P. Autoreactive CD8 T cells in organ-specific autoimmunity: Emerging targets for therapeutic intervention. Immunity. 2002; 17(1):1-6.
CrossRef
- Canas CA. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med Hypothes. 2020;145:110345.
CrossRef
PubMed PubMedCentral
- Kanduc D. From Anti-SARS-CoV-2 Immune responses to COVID-19 via molecular mimicry. Antibodies. 2020;9(3):33.
CrossRef
PubMed PubMedCentral
- Kanduc D, Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: Implications for the vaccine. Immunol Res. 2020;68(5):310-3.
CrossRef
PubMed PubMedCentral
- Saheb Sharif-Askari N, Saheb Sharif-Askari F, Ahmed SBM, Hannawi S, Hamoudi R, Hamid Q, et al. Enhanced expression of autoantigens during SARS-CoV-2 viral infection. Front Immunol. 2021;12:686462.
CrossRef
PubMed PubMedCentral
- Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012;42(1):102-11.
CrossRef
PubMed PubMedCentral
- Rojas M, Restrepo-Jiménez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100-23.
CrossRef
PubMed
- Karami Fath M, Jahangiri A, Ganji M, Sefid F, Payandeh Z, Hashemi ZS, et al. SARS-CoV-2 proteome harbors peptides which are able to trigger autoimmunity responses: Implications for infection, vaccination, and population coverage. Front Immunol. 2021 Aug 10;12:705772.
CrossRef
PubMed PubMedCentral
- Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J. The association between severe or dead COVID-19 and autoimmune diseases: A systematic review and metaanalysis. J Infect. 2020;81(3):e93-5.
CrossRef
PubMed PubMedCentral
- Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 Oct 23;370(6515):eabd4585.
- Woodruff MC, Ramonell RP, Lee FE-H, Sanz I. Clinically identifiable autoreactivity is common in severe SARSCoV-2 infection. Infect Dis (except HIV/AIDS) 1400 (2020).
- Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020 Nov;13(6):1077-1086.
CrossRef
PubMed PubMedCentral
- Wang EY, Mao T, Klein J, Dai Y, Huck JD, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021; 595:283-8.
CrossRef
PubMed
- Saheb Sharif-Askari N, Saheb Sharif-Askari F, Ahmed SBM, Hannawi S, Hamoudi R, Hamid Q, Halwani R. Enhanced expression of autoantigens during SARSCoV-2 viral infection. Front Immunol. 2021 Jun 30;12:686462.
CrossRef
PubMed PubMedCentral
- Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute Covid-19. JAMA. 2020; 324(6):603-5.
CrossRef
PubMed PubMedCentral
- Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An Outbreak of Severe KawasakiLike Disease at the Italian Epicentre of the SARS-CoV-2 Epidemic: An observational cohort study. Lancet. 2020;395(10239):1771-8.
CrossRef
- Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, et al. Vasculitis Changes in COVID-19 Survivors With Persistent Symptoms. Eur J Nucl Med Mol Imag.2021; 48(5):1460-6.
CrossRef
PubMed PubMedCentral
- Mahase E. Covid-19: What do we know about "Long covid?". BMJ. 2020; 370:m2815.
CrossRef
PubMed
- Burbelo PD, Iadarola MJ, Alevizos I, Sapio MR. Transcriptomic segregation of human autoantigens useful for the diagnosis of autoimmune diseases. Mol Diagn Ther. 2016;20(5):415-27.
CrossRef
PubMed PubMedCentral
- Franke C, Ferse C, Kreye J, Reincke SM, SanchezSendin E, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021 Mar;93:415-9.
CrossRef
PubMed PubMedCentral
- Matschke J, Lütgehetmann M, Hagel C, Sperhake JP, Schröder AS, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919-29.
CrossRef
- Suurmond J, Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest. 2015;125(6):2194-202.
CrossRef
PubMed PubMedCentral
- Prüss H. Postviral autoimmune encephalitis: manifestations in children and adults. Current Opin Neurol. 2017;30(3):327-33.
CrossRef
PubMed
- Mehta P, McAuley F, Brown M. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033.
CrossRef
|
|
|
|
|
|
|